Citi names its top biotech stock picks for 2023 — and gives one 73% upside
Biotech has been a "stock-pickers market" — and it may have just what it takes to remain one in 2023,
Read more
Apellis Pharmaceuticals Inc
Citi names its ‘highest conviction ideas’ for the second half of 2022 — and gives one upside of 85%
Ssome companies tend to weather an inflationary environment better than competitors because they can pass on higher costs to customers.
Read more